| Company Name: | Amedisys, Inc. | | Ticker Symbol: | AMED | | | WWW Address: | www.amedisys.com |
| CEO: | William F. Borne | | No. of Employees: | 15,200 |
| Common Issue Type: | CS | | Business Description: | Amedisys, Inc., is a health care company engaged in delivering personalized health care services to patients and their families.
|
| | | Industry Information: | HEALTH SERVICES - Home Health Care [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 11.27 |  0.14 | 10.11 | 14.41 | 11.16 | 11.50 | 11.11 | 357042 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 354.6 | 31.5 | 0.70 | -2.79 | 0.00 | 0.0 | 0.0 | 15.95 - 8.81 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 11.27 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 354.6 | mil |
| Latest Shares Outstanding | 31.5 | mil |
| Earnings pS (EPS) | -2.79 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 97,888 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 26.1 | mil |
| Float as % of Shares Outstanding | 83.2 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 37.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 43.4 | % |
| EBITDA Margin | 5.7 | % |
| Pre-Tax Profit Margin | -8.7 | % |
| Assets Turnover | 1.9 | % |
| Return on Assets (ROA) | -14.3 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -20.3 | % |
| Current Ratio | 0.9 | |
| Leverage Ratio (Assets/Equity) | 1.5 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.17 | |
| LT Debt/Total Capital | 9.0 | % |
| Working Capital pS | -0.65 | $ |
| Cash pS | 0.22 | $ |
| Book-Value pS | 14.63 | $ |
| Tangible Book-Value pS | 6.47 | $ |
| Cash Flow pS | -1.93 | $ |
| Free Cash Flow pS | 0.91 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.77 | |
| Price/Tangible Book Ratio | 1.74 | |
| Price/Cash Flow | -5.8 | |
| Price/Free Cash Flow | 12.4 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.3 | 99 | 3,369 | 12,573 |
| 4 Weeks | 11.50 | 8.81 | 10.41 | 8.3 | 101 | 4,347 | 86,945 |
| 13 Weeks | 13.36 | 8.81 | 12.92 | -12.8 | 80 | 3,885 | 244,740 |
| 26 Weeks | 13.36 | 8.81 | 9.65 | 16.8 | 95 | 3,387 | 419,979 |
| 52 Weeks | 15.95 | 8.81 | 10.00 | 12.7 | 88 | 3,325 | 828,030 |
| YTD | 13.36 | 8.81 | - | -0.3 | 85 | 3,624 | 344,319 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 11.13 | 10.92 | 10.92 | 11.14 | 11.94 | 0.70 | 1.23 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 9.94 | 50.1 | -2.88 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -18.80 | NA | -4.13 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -8.5 | -8.5 | 1.2 |
| Earnings % | -61.0 | -61.0 | 0.0 |
| EPS % | -50.0 | -50.0 | 0.0 |
| EPS $ | -0.09 | -0.09 | 10.54 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 0.14 |
| Current Ratio | 1.0 |
| Quick Ratio (Acid Test) | 0.9 |
| Liquidity Ratio (Cash) | 0.07 |
| Receivables Turnover | 9.4 |
| Average Collection Period | 38 |
| Working Capital/Equity | 0.2 |
| Working Capital pS | 0.03 |
| Cash-Flow pS | -1.84 |
| Free Cash-Flow pS | 0.27 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.10 |
| Financial Leverage Ratio (Assets/Equity) | 1.6 |
| Debt Ratio | 38.1 |
| Total Debt/Equity (Gearing Ratio) | 0.23 |
| LT Debt/Equity | 0.15 |
| LT Debt/Capital Invested | 14.1 |
| LT Debt/Total Liabilities | 24.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 2.31 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 22.81 |
| Tobin's Q Ratio | 0.49 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 6.77 |
| Enterprise Value (EV)/Free Cash Flow | 217.36 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 1.74 |
| Price/Book Ratio - LTM | 0.77 |
| Price/Cash Flow Ratio | -5.8 |
| Price/Free Cash Flow Ratio - LTM | 12.4 |
| Price/Sales Ratio | 0.24 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 9.9 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 6.6 |
| PER SHARE FIGURES |
| LT Debt pS | 2.15 |
| Current Liabilities pS | 6.59 |
| Tangible Book Value pS - LTM | 6.47 |
| Book Value pS - LTM | 14.63 |
| Capital Invested pS | 16.50 |
| Cash pS - LTM | 0.22 |
| Cash Flow pS - LTM | -1.93 |
| Free Cash Flow pS - LTM | 0.91 |
| Earnings pS (EPS) | -2.79 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 0.57 |
| Free Cash Flow Margin 5YEAR AVG | -2.65 |
| Net Profit Margin | -6.6 |
| Net Profit Margin - 5YEAR AVRG. | -6.6 |
| Equity Productivity | 3.29 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 2.87 |
| Return on Capital Invested (ROCI) | -19.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -12.3 |
| Assets Productivity | 1.90 |
| Return on Assets (ROA) | -13.5 |
| Return on Assets (ROA) - 5YEAR AVRG. | -9.4 |
| Gross Profit Margin | 43.4 |
| Gross Profit Margin - 5YEAR AVRG. | 49.0 |
| EBITDA Margin - LTM | 5.7 |
| EBIT Margin - LTM | -7.9 |
| Pre-Tax Profit Margin | -8.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -0.7 |
| Effective Tax Rate | 18.0 |
| Effective Tax Rate - 5YEAR AVRG. | 31.2 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 41 |
| Revenue per Employee | 97,888 |
| Net Income per Employee | -6,486 |
| Average Collection Period | 41 |
| Receivables Turnover | 9.4 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 1.96 |
| Assets/Revenue | 0.53 |
| Net Working Capital Turnover | 1,486.42 |
| Fixed Assets Turnover | 2.84 |
| Total Assets Turnover | 1.9 |
| Revenue per $ Cash | 102.30 |
| Revenue per $ Plant | 9.49 |
| Revenue per $ Common Equity | 3.29 |
| Revenue per $ Capital Invested | 2.87 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 37.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 33.9 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
